Prototype Test For Predicting Clinical Outcome For Melanoma Patients

Investigators have developed a test to predict whether a patient will progress rapidly from Stage III melanoma to metastatic Stage IV cancer and death. More than 70% of patients with Stage III melanoma — melanoma that has spread to the lymph nodes — will typically have a rapid time to progression (TTP) to Stage IV melanoma, and pass away within five years of their diagnosis.

Read the whole article on Science Daily

More from Science Daily